Trial
NCT03348163
(mo)BETTA Trial in Transwomen for Optimization of ART
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
Gilead Sciences
Condition
HIV Infections
Intervention
B/FTC/TAF
Why stopped
Lack of ability to recruit due to COVID-19 pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-03